| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.634 | 26.870 | 19.735 | 16.973 | 25.720 | 30.769 | 51.215 | 51.374 | 52.523 | 46.627 |
| Total Income - EUR | 26.803 | 26.882 | 22.800 | 31.096 | 37.568 | 40.741 | 56.366 | 52.615 | 52.530 | 46.635 |
| Total Expenses - EUR | 22.303 | 23.616 | 31.140 | 30.066 | 27.748 | 29.351 | 36.415 | 30.790 | 24.164 | 29.445 |
| Gross Profit/Loss - EUR | 4.500 | 3.266 | -8.340 | 1.030 | 9.821 | 11.390 | 19.951 | 21.825 | 28.366 | 17.189 |
| Net Profit/Loss - EUR | 3.696 | 2.997 | -9.509 | 860 | 9.563 | 11.085 | 19.449 | 21.388 | 27.936 | 16.746 |
| Employees | 3 | 3 | 4 | 4 | 2 | 3 | 4 | 3 | 2 | 2 |
Check the financial reports for the company - Medvet Costy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.562 | 5.358 | 55.032 | 40.618 | 26.688 | 15.022 | 8.933 | 4.659 | 4.165 | 3.886 |
| Current Assets | 31.852 | 43.399 | 58.308 | 58.574 | 80.748 | 87.064 | 93.590 | 144.456 | 176.269 | 203.200 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.262 | 2.224 | 3.937 |
| Receivables | 11.339 | 37.101 | 29.171 | 15.505 | 21.329 | 24.345 | 34.636 | 23.722 | 165.128 | 194.496 |
| Cash | 20.512 | 6.298 | 29.137 | 43.068 | 59.420 | 62.719 | 58.954 | 119.472 | 8.917 | 4.766 |
| Shareholders Funds | 23.061 | 25.823 | 15.877 | 16.471 | 25.716 | 36.313 | 54.957 | 76.515 | 104.219 | 120.383 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 14.352 | 22.934 | 33.216 | 33.737 | 45.463 | 40.124 | 47.566 | 53.761 | 57.433 | 68.026 |
| Income in Advance | 0 | 0 | 64.247 | 48.984 | 36.258 | 25.649 | 0 | 18.839 | 18.782 | 18.677 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Medvet Costy Srl